Chimerix Profit Margin

The latest profit margin for CMRX is -416.92% as of December 2024. That compares with -244.6% in the prior-year period — down 70.5% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Chimerix's historical trend and sector peers before judging valuation or financial health.

Over the past year, CMRX's profit margin moved from -244.6% to -416.92% — a 70.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chimerix's valuation or profitability profile.

Against Healthcare companies, CMRX currently prints -416.92% for profit margin, while the sector average sits near 15.58%. That is roughly 267630.1% below the sector mean. Large gaps often invite a closer look at Chimerix's growth, margins, and balance sheet.

Profit Margin shows how effectively Chimerix converts resources into returns. At -416.92%, CMRX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -244.6% in the prior-year period — down 70.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CMRX's profit margin (-416.92%), review year-over-year change from -244.6%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.